-
1
-
-
0029586031
-
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
-
Duchmann R, Kaiser L. Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102: 448-455
-
(1995)
Clin Exp Immunol
, vol.102
, pp. 448-455
-
-
Duchmann, R.1
Kaiser, L.2
Hermann, E.3
Mayet, W.4
Ewe, K.5
Meyer zum Buschenfelde, K.H.6
-
2
-
-
0038337828
-
Targeting enterk bacteria in treatment of inflammatory bowel diseases: Why, how, and when
-
Sartor RB. Targeting enterk bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr Opin Gastrointerol 2003; 19:358-365
-
(2003)
Curr Opin Gastrointerol
, vol.19
, pp. 358-365
-
-
Sartor, R.B.1
-
3
-
-
0042708022
-
-
Greenstein RJ. is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 2003; 3: 507 514
-
Greenstein RJ. is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 2003; 3: 507 514
-
-
-
-
4
-
-
10944261455
-
Serologic markers in inflammatory bowel disease: State of the art
-
Sandborn WJ. Serologic markers in inflammatory bowel disease: state of the art. Rev Gastroenterol Disord 2004; 4: 167-174
-
(2004)
Rev Gastroenterol Disord
, vol.4
, pp. 167-174
-
-
Sandborn, W.J.1
-
5
-
-
0038644758
-
Colombel ff. Serological markers in inflammatory bowel diseases
-
Reumaux D, Sendid B, Poulain D, Duthilleul P, Dewit O, Colombel ff. Serological markers in inflammatory bowel diseases. Best Pract Res Clin Gastroenterol 2003; 17: 19-35
-
(2003)
Best Pract Res Clin Gastroenterol
, vol.17
, pp. 19-35
-
-
Reumaux, D.1
Sendid, B.2
Poulain, D.3
Duthilleul, P.4
Dewit, O.5
-
6
-
-
0023698058
-
Antibody to Saccharomyces cerevisiae (bakers'yeast) in Crohn's disease
-
Main J, McKenzie H, Yeaman GR, Kerr MA, Robson D, Pennington CR, Parratt D. Antibody to Saccharomyces cerevisiae (bakers'yeast) in Crohn's disease. BMJ 1988; 297: 1105-1106
-
(1988)
BMJ
, vol.297
, pp. 1105-1106
-
-
Main, J.1
McKenzie, H.2
Yeaman, G.R.3
Kerr, M.A.4
Robson, D.5
Pennington, C.R.6
Parratt, D.7
-
7
-
-
23944492085
-
ASCA: Genetic marker, predictor of disease, or marker of a response to an environmental antigen?
-
Seiboid F. ASCA: genetic marker, predictor of disease, or marker of a response to an environmental antigen? Gut 2005; 54: 1212-1213
-
(2005)
Gut
, vol.54
, pp. 1212-1213
-
-
Seiboid, F.1
-
8
-
-
0035120813
-
Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: A family study
-
Seibold F, Stich O, Hufnagl R, Kamil S, Scheurlen M. Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study. Scand J Gastroenterol 2001; 36: 196-201.
-
(2001)
Scand J Gastroenterol
, vol.36
, pp. 196-201
-
-
Seibold, F.1
Stich, O.2
Hufnagl, R.3
Kamil, S.4
Scheurlen, M.5
-
9
-
-
0029883566
-
Specific antibody response to oligomannosidic epitopes in Crohn's disease
-
Sendid B. Colombel JF, Jacquinot PM, Faille C. Fruit J. Cortot A, Lucidarme D, Camus D, Poulain D. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 1996; 3: 219-226
-
(1996)
Clin Diagn Lab Immunol
, vol.3
, pp. 219-226
-
-
Sendid, B.1
Colombel, J.F.2
Jacquinot, P.M.3
Faille, C.4
Fruit, J.5
Cortot, A.6
Lucidarme, D.7
Camus, D.8
Poulain, D.9
-
10
-
-
0345269763
-
A Saccharomyces cerevisiae mutant with increased virulence
-
Wheeler RT, Kupiec M, Magnelli P, Abeijon C, Fink GR. A Saccharomyces cerevisiae mutant with increased virulence. Proc Natl Acad Sci USA 2003; 100: 2766-2770
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 2766-2770
-
-
Wheeler, R.T.1
Kupiec, M.2
Magnelli, P.3
Abeijon, C.4
Fink, G.R.5
-
11
-
-
33646381860
-
Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease
-
Standaert-Vitse A, Jouault T, Vandewalle P, Mille C, Seddik M Sendid B Mallet JM, Colombel JF, Poulain D. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology 2006; 130: 1764-1775
-
(2006)
Gastroenterology
, vol.130
, pp. 1764-1775
-
-
Standaert-Vitse, A.1
Jouault, T.2
Vandewalle, P.3
Mille, C.4
Seddik, M.5
Sendid, B.6
Mallet, J.M.7
Colombel, J.F.8
Poulain, D.9
-
12
-
-
36749049239
-
Anti-Saccharomyces cerevisiae marman antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans
-
Schaffer T, Muller S, Flogerzi B, Seibold-Schmid B, Schoepfer AM, Seibold F. Anti-Saccharomyces cerevisiae marman antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflamm Bowel Dis 2007, 13: 1339-1346
-
(2007)
Inflamm Bowel Dis
, vol.13
, pp. 1339-1346
-
-
Schaffer, T.1
Muller, S.2
Flogerzi, B.3
Seibold-Schmid, B.4
Schoepfer, A.M.5
Seibold, F.6
-
13
-
-
0031764693
-
Characterization of oligosaccharides from an antigenic marman of Saccharomyces cerevisiae
-
Young M, Davies MJ, Bailey D, Gradwell MJ, Smestad-Paulsen B, Wold JK, Barnes RM, Hounsell EF. Characterization of oligosaccharides from an antigenic marman of Saccharomyces cerevisiae. Glyroconj J 1998; 15: 815-822
-
(1998)
Glyroconj J
, vol.15
, pp. 815-822
-
-
Young, M.1
Davies, M.J.2
Bailey, D.3
Gradwell, M.J.4
Smestad-Paulsen, B.5
Wold, J.K.6
Barnes, R.M.7
Hounsell, E.F.8
-
14
-
-
0031315805
-
The mycobacterial cell wall: Structure, biosynthesis and sites of drug action
-
Chatterjee D. The mycobacterial cell wall: structure, biosynthesis and sites of drug action. Curr Opin Chem Biol 1990; 1: 579-588
-
(1990)
Curr Opin Chem Biol
, vol.1
, pp. 579-588
-
-
Chatterjee, D.1
-
15
-
-
0038175124
-
Lipoarabinomannans: From structure to biosynthesis
-
Nigou J, Gilleron M, Puzo G. Lipoarabinomannans: from structure to biosynthesis. Biochimie 2003; 85: 1153-1166
-
(2003)
Biochimie
, vol.85
, pp. 1153-1166
-
-
Nigou, J.1
Gilleron, M.2
Puzo, G.3
-
16
-
-
0024286486
-
Binding properties of a mannose-specific lectin from the snowdrop (Galanthus nivalis) bulb
-
Shibuya N, Goldstein IJ, Van Damme EJ, Peumans WJ. Binding properties of a mannose-specific lectin from the snowdrop (Galanthus nivalis) bulb. J Biol Chem 1988; 263: 728-734
-
(1988)
J Biol Chem
, vol.263
, pp. 728-734
-
-
Shibuya, N.1
Goldstein, I.J.2
Van Damme, E.J.3
Peumans, W.J.4
-
17
-
-
0026170577
-
interactions of five D-mannose-specific lectins with a series of synthetic branched trisaccharides
-
Kaku H, Goldstein IJ, Oscarson S. interactions of five D-mannose-specific lectins with a series of synthetic branched trisaccharides. Carbohydr Res 1991; 213; 109-116
-
(1991)
Carbohydr Res
, vol.213
, pp. 109-116
-
-
Kaku, H.1
Goldstein, I.J.2
Oscarson, S.3
-
18
-
-
0037163136
-
Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with alpha 1,3-mannopyranose side chains
-
Guerardel Y, Maes E, Flass E, Leroy Y, Timmerman P, Besra GS, Locht C, Strecker G, Kremer L. Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with alpha 1,3-mannopyranose side chains. J Biol Chem 2002; 277: 30635-30648
-
(2002)
J Biol Chem
, vol.277
, pp. 30635-30648
-
-
Guerardel, Y.1
Maes, E.2
Flass, E.3
Leroy, Y.4
Timmerman, P.5
Besra, G.S.6
Locht, C.7
Strecker, G.8
Kremer, L.9
-
19
-
-
0037507310
-
The MPB83 antigen from Mycobacterium bovis contains O-linked mannose and (1 >3)-mannobiose moieties
-
Michell SL, Whelan AO, Wheeler PR, Panico M, Easton RL, Etienne AT, Hasiam SM, Dell A, Morris HR, Reason Al, Herrmann JI, Young DB, Hewinson RG. The MPB83 antigen from Mycobacterium bovis contains O-linked mannose and (1 >3)-mannobiose moieties. J Boil Chem 2003, 278: 16423-16432
-
(2003)
J Boil Chem
, vol.278
, pp. 16423-16432
-
-
Michell, S.L.1
Whelan, A.O.2
Wheeler, P.R.3
Panico, M.4
Easton, R.L.5
Etienne, A.T.6
Hasiam, S.M.7
Dell, A.8
Morris, H.R.9
Reason, A.10
Herrmann, J.I.11
Young, D.B.12
Hewinson, R.G.13
-
20
-
-
35648936533
-
Microbial mannan inhibits bacterial killing by macrophages: A possible pathogenic mechanism for Crohn's disease
-
Mpofu CM, Campbell BJ, Subramanian S, Marshall-Clarke S, Harl CA, Cross A, Roberts CL, McGoldrick A, Edwards SW, Rhodes JM. Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Gastroenterology 2007; 133: 1487-1498
-
(2007)
Gastroenterology
, vol.133
, pp. 1487-1498
-
-
Mpofu, C.M.1
Campbell, B.J.2
Subramanian, S.3
Marshall-Clarke, S.4
Harl, C.A.5
Cross, A.6
Roberts, C.L.7
McGoldrick, A.8
Edwards, S.W.9
Rhodes, J.M.10
-
21
-
-
0036712128
-
Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients
-
Shafran I, Piromalli C, Decker JW, Sandoval J, Naser SA, EI-Zaatari FA. Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients. Dig Dis Sci 2002; 47: 2079-2081
-
(2002)
Dig Dis Sci
, vol.47
, pp. 2079-2081
-
-
Shafran, I.1
Piromalli, C.2
Decker, J.W.3
Sandoval, J.4
Naser, S.A.5
EI-Zaatari, F.A.6
-
22
-
-
0034694984
-
Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis
-
Naser SA, Hulten K, Shafran I, Graham DY, EI-Zaatari FA. Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis. Vet Microbiol 2000; 77: 497-504
-
(2000)
Vet Microbiol
, vol.77
, pp. 497-504
-
-
Naser, S.A.1
Hulten, K.2
Shafran, I.3
Graham, D.Y.4
EI-Zaatari, F.A.5
-
23
-
-
0031720252
-
Mannose-Joinding lectin (MBL) in health and disease
-
Turner MW. Mannose-Joinding lectin (MBL) in health and disease. Immunobiology 1998; 199: 327-339
-
(1998)
Immunobiology
, vol.199
, pp. 327-339
-
-
Turner, M.W.1
-
24
-
-
0033052588
-
C-type lecthns and galecthns mediate innate and adaptive immune functions: Their roles in the complement activation pathway
-
Vasta GR, Quesenberry M, Ahmed H, O'Leary N. C-type lecthns and galecthns mediate innate and adaptive immune functions: their roles in the complement activation pathway. Dev Comp Immunol 1999; 23: 401-420
-
(1999)
Dev Comp Immunol
, vol.23
, pp. 401-420
-
-
Vasta, G.R.1
Quesenberry, M.2
Ahmed, H.3
O'Leary, N.4
-
25
-
-
0034999785
-
Mannose-binding lectin: Targeting the microbial world for complement attack and opsonophagocytosis
-
Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 2001; 180: 86-99
-
(2001)
Immunol Rev
, vol.180
, pp. 86-99
-
-
Jack, D.L.1
Klein, N.J.2
Turner, M.W.3
-
27
-
-
5144227750
-
Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease
-
Seibold F, Konrad A, Flogerzi B, Seibold-Schmid B, Arni S, Juliger S, Kun JF. Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease. Gastroenterology 2004; 127: 1076-1084
-
(2004)
Gastroenterology
, vol.127
, pp. 1076-1084
-
-
Seibold, F.1
Konrad, A.2
Flogerzi, B.3
Seibold-Schmid, B.4
Arni, S.5
Juliger, S.6
Kun, J.F.7
-
28
-
-
33846006593
-
Deficiency for mannan-binding fectin is associated with antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their relatives
-
Seibold F, Boldt AB, Seibold-Schmid B, Schoepfer AM, Flogerzi B, Muller S, Kun JF. Deficiency for mannan-binding fectin is associated with antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their relatives. Gut 2007; 56: 152
-
(2007)
Gut
, vol.56
, pp. 152
-
-
Seibold, F.1
Boldt, A.B.2
Seibold-Schmid, B.3
Schoepfer, A.M.4
Flogerzi, B.5
Muller, S.6
Kun, J.F.7
-
29
-
-
0017227303
-
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
-
Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-444
-
(1976)
Gastroenterology
, vol.70
, pp. 439-444
-
-
Best, W.R.1
Becktel, J.M.2
Singleton, J.W.3
Kern Jr., F.4
-
30
-
-
0023521441
-
Coated oral 3-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study
-
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 3-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl I Med 1987; 317: 1625-1629
-
(1987)
N Engl I Med
, vol.317
, pp. 1625-1629
-
-
Schroeder, K.W.1
Tremaine, W.J.2
Ilstrup, D.M.3
-
31
-
-
33646778482
-
The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications
-
Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753
-
(2006)
Gut
, vol.55
, pp. 749-753
-
-
Satsangi, J.1
Silverberg, M.S.2
Vermeire, S.3
Colombel, J.F.4
-
32
-
-
0014634728
-
Method for fingerprinting yeast cell wall mannans
-
Kocourek J, Ballou CE. Method for fingerprinting yeast cell wall mannans, J Bacteriol 1969; 100: 1175-1181
-
(1969)
J Bacteriol
, vol.100
, pp. 1175-1181
-
-
Kocourek, J.1
Ballou, C.E.2
-
33
-
-
0033805362
-
Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics
-
Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Nam; H, Targan SR. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000; 47: 487-496
-
(2000)
Gut
, vol.47
, pp. 487-496
-
-
Vasiliauskas, E.A.1
Kam, L.Y.2
Karp, L.C.3
Gaiennie, J.4
Nam, H.5
Targan, S.R.6
-
34
-
-
34249313972
-
Antibodies to saccharomyces cerevisiae in Crohn's disease: Higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease
-
Dassopoulos T, Frangakis C, Cruz-Correa M, Talor MV, Burek CL, Datta L, Nouvet F, Bayless TM, Brant SR. Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease. Inflamm Bowel Dis 2007; 13: 143-151
-
(2007)
Inflamm Bowel Dis
, vol.13
, pp. 143-151
-
-
Dassopoulos, T.1
Frangakis, C.2
Cruz-Correa, M.3
Talor, M.V.4
Burek, C.L.5
Datta, L.6
Nouvet, F.7
Bayless, T.M.8
Brant, S.R.9
-
35
-
-
3242698642
-
Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease
-
Forcione DG, Rosen MJ, Kisiel JB, Sands BE. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut 2004; 53: 1117-1122
-
(2004)
Gut
, vol.53
, pp. 1117-1122
-
-
Forcione, D.G.1
Rosen, M.J.2
Kisiel, J.B.3
Sands, B.E.4
-
36
-
-
0035121977
-
Elevated antibody responses in patients with Crohn's disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis
-
Olsen I, Wiker HG, Johnson E, Langeggen H, Reitan LJ. Elevated antibody responses in patients with Crohn's disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis. Scand J Immunol 2001; 53: 198-203
-
(2001)
Scand J Immunol
, vol.53
, pp. 198-203
-
-
Olsen, I.1
Wiker, H.G.2
Johnson, E.3
Langeggen, H.4
Reitan, L.J.5
-
37
-
-
33745755063
-
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?
-
Polymeros D, Bogdanos DP, Day R, Arioli D, Vergani D, Forbes A. Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? Gastroenterology 2006; 131: 85-96
-
(2006)
Gastroenterology
, vol.131
, pp. 85-96
-
-
Polymeros, D.1
Bogdanos, D.P.2
Day, R.3
Arioli, D.4
Vergani, D.5
Forbes, A.6
-
38
-
-
31844441031
-
Serologic markers in inflammatory bowel disease
-
Bossuyt X. Serologic markers in inflammatory bowel disease. Clin Chem 2006; 52: 17l-181
-
(2006)
Clin Chem
, vol.52
-
-
Bossuyt, X.1
-
39
-
-
4644276477
-
The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages
-
Stokes RW, Norris-Jones R, Brooks DE, Beveridge TJ, Doxsee D, Thorson LM. The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages. Infect Immun 2004; 72: 5676-5686
-
(2004)
Infect Immun
, vol.72
, pp. 5676-5686
-
-
Stokes, R.W.1
Norris-Jones, R.2
Brooks, D.E.3
Beveridge, T.J.4
Doxsee, D.5
Thorson, L.M.6
-
40
-
-
0026640822
-
Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains
-
Chatterjee D, Lowell K, Rivoire B, McNeil MR, Brennan PJ. Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J Biol Chem 1992; 267: 6234-6239
-
(1992)
J Biol Chem
, vol.267
, pp. 6234-6239
-
-
Chatterjee, D.1
Lowell, K.2
Rivoire, B.3
McNeil, M.R.4
Brennan, P.J.5
-
41
-
-
0031951727
-
Mycobacterial lipoarabinomannan: An extraordinary lipoheteroglycan with profound physiological effects
-
Chatterjee D, Khoo KH. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 1998; 8: 113-120
-
(1998)
Glycobiology
, vol.8
, pp. 113-120
-
-
Chatterjee, D.1
Khoo, K.H.2
-
42
-
-
0001023242
-
Relationships between the structure and the roles ot lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis
-
Vercellone A, Nigou J, Puzo G. Relationships between the structure and the roles ot lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis. Front Biosci 1998; 3: e149-e163
-
(1998)
Front Biosci
, vol.3
-
-
Vercellone, A.1
Nigou, J.2
Puzo, G.3
-
43
-
-
0141724527
-
Mannose-binding lectin polymorphisms in clinical tuberculosis
-
Soborg C, Madsen HO, Andersen AB, Lillebaek T, Kok-Jensen A, Garred P. Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis 2003; 188: 777-782
-
(2003)
J Infect Dis
, vol.188
, pp. 777-782
-
-
Soborg, C.1
Madsen, H.O.2
Andersen, A.B.3
Lillebaek, T.4
Kok-Jensen, A.5
Garred, P.6
-
44
-
-
30944451959
-
Mannose-binding lectin enhances the attachment and phagocytosis of mycobacteria in vitro
-
Bonar A, Chmiela M, Rudnicka W, Rozalska B. Mannose-binding lectin enhances the attachment and phagocytosis of mycobacteria in vitro. Arch Immunol Ther Exp (Warsz) 2005; 53: 437-441
-
(2005)
Arch Immunol Ther Exp (Warsz)
, vol.53
, pp. 437-441
-
-
Bonar, A.1
Chmiela, M.2
Rudnicka, W.3
Rozalska, B.4
-
45
-
-
34948873645
-
Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospliolipid syndrome
-
Krause I, Blank M, Cervera R, Font J, Matthias T, Pfeiffer S, Wies I, Fraser A, Shoenfeld Y. Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospliolipid syndrome. Ann N Y Acad Sci 2007; 1108: 481-488
-
(2007)
Ann N Y Acad Sci
, vol.1108
, pp. 481-488
-
-
Krause, I.1
Blank, M.2
Cervera, R.3
Font, J.4
Matthias, T.5
Pfeiffer, S.6
Wies, I.7
Fraser, A.8
Shoenfeld, Y.9
-
46
-
-
11144266571
-
Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype
-
Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 2004; 99: 2376-2384
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 2376-2384
-
-
Arnott, I.D.1
Landers, C.J.2
Nimmo, E.J.3
Drummond, H.E.4
Smith, B.K.5
Targan, S.R.6
Satsangi, J.7
|